Why Finance With Brobas Capital Partners
Scale Station by Station
Add two stations or twelve on one facility. Financing lets a center grow capacity as its census grows, so you are not fronting the cash for a full floor before the chairs are filled.
Machines, Water, and Chairs Together
Hemodialysis machines are only part of a station. We finance the reverse-osmosis water treatment, concentrate delivery, and treatment chairs on the same schedule, so the whole station goes in as one line.
Refurbished Fresenius, Fully Funded
Certified refurbished Fresenius 2008T machines run well below new and are a mainstay of cost-conscious centers. We finance new and refurbished on the same terms, so you can mix and match by station.
All Credit Profiles Considered
New centers and owners with challenged credit still get funded through our 500+ lender network. We shop the deal to the lender that understands dialysis, rather than running one bank and quitting.
The Dialysis Equipment We Finance
A dialysis station is more than the machine, and we finance the whole station. The hemodialysis machine is the anchor: the Fresenius 2008T is the US workhorse, with integrated online clearance (Kt/V) monitoring and the BlueStar sensor, and the newer Fresenius 6008 CAREsystem is entering more centers. The B. Braun Dialog+ and Dialog iQ are widely used alternatives, and Nipro Surdial X and Baxter Artis appear as well. For home and low-infrastructure settings, the Outset Tablo integrates water purification into the machine, and NxStage systems support home hemodialysis.
Behind the machines sits the water treatment plant, usually the biggest single line: a central reverse-osmosis system from Mar Cor or Evoqua, loop piping, and concentrate delivery for Fresenius Granuflo or Naturalyte. Each station also needs a dialysis treatment chair, such as a Champion or Transmotion recliner, plus monitoring and the station buildout itself.
We finance the machines, the RO and water loop, concentrate systems, chairs, and installation together. Whether you are adding two stations or building a twelve-chair floor, the whole package can sit on one facility.
Recent Funded Approvals
Representative dialysis deals placed for US nephrology groups and centers.
- $465,000, twelve-station buildout, Newark NJ nephrology group. Twelve Fresenius 2008T machines, a Mar Cor central RO system, and Champion treatment chairs. Eight years in practice, 725 owner credit. Approved at 6.24% APR over 72 months with 10 percent down, the full floor on one facility. This is our anchor station-by-station rollout.
- $88,000, two-station addition, Fresenius 2008T machines plus water, established center, Baltimore MD. Fifteen years in practice, 738 credit. 5.74% APR over 60 months, $0 down.
- $42,000, single B. Braun Dialog+ machine, station replacement, Cleveland OH. Six years in practice, 700 credit. 6.49% APR over 60 months, $0 down, application-only.
- $310,000, home hemodialysis program, eight Outset Tablo systems, growing nephrology practice, Detroit MI. Four years in practice, 712 credit. 6.74% APR over 66 months with 10 percent down.
Each rate reflects that file's credit and term. Qualified groups start from 5.49% APR after a soft review.
Per-Station Utilization, the ESRD Bundle, and Section 179
Dialysis revenue is a per-treatment, per-station business, which is exactly why financing station by station works. Under the Medicare ESRD Prospective Payment System, each hemodialysis treatment is reimbursed on a bundled per-session base rate (roughly the high $200s per treatment in 2026, before adjusters), and a typical in-center patient receives about three treatments a week, or roughly thirteen a month. A single station running multiple shifts can serve several patients across a day, six days a week, so each chair generates a predictable stream that comfortably exceeds its financed cost. Adding capacity as census grows means the new stations begin billing almost as soon as they are commissioned.
Section 179 strengthens the case. A center can deduct the full cost of qualifying machines, water treatment, and chairs in the year they are placed in service, up to the annual cap, about $2.5 million in 2026, instead of depreciating the equipment over years. 100 percent bonus depreciation can apply on top, which matters on a $465,000 twelve-station build. A group in a 32 percent bracket can capture well into six figures of first-year deductions while paying the note over 72 months out of treatment revenue. Finance the stations, deduct the cost now, and let per-treatment billing service the payment. Confirm the current ESRD base rate and Section 179 limits with your accountant, since both change annually.
Who Qualifies and How to Apply
Brobas Capital Partners is a medical equipment finance broker with more than 500 US lenders behind it, which is how we fund dialysis centers that a single bank would turn away. Established nephrology groups, brand-new centers, and owners with challenged credit all have a path, because we place each deal with a lender who understands dialysis economics rather than running the file once and stopping.
For smaller adds up to $150,000, funding is often application-only: a one-page application and a soft credit look, usually a same-day decision, no tax returns. Full center builds above $150,000 typically ask for two years of returns, recent bank statements, and the equipment and water-treatment quote, still on a fast track. Approved funds go to Fresenius, B. Braun, Outset, or your water-treatment vendor so delivery and install can be scheduled.
Structures include $0 down or modest down payments, 60 to 90 day deferred starts while a new center credentials and commissions its water system, fair-market-value leases, and dollar-buyout agreements so you own the machines at term. Tell us your station count, the machines you are quoting, and your census plan, and we will build a single-facility payment from 5.49% APR for qualified groups. Rates are quoted after review and never guaranteed.
Frequently Asked Questions
What does it cost to finance a dialysis station?
All-in, a station runs $20,000 to $60,000 depending on the machine and its share of water treatment and the chair. Financed from 5.49% APR over 72 months, a twelve-station build near $465,000 lands around $7,600 a month for a qualified group. Rate depends on credit, time in practice, and term.
Do you finance the water treatment system too?
Yes. Central reverse-osmosis systems from Mar Cor or Evoqua, portable RO units, and concentrate delivery are financed alongside the machines on one facility. Water treatment is often the single largest line in a buildout, and we fund it with the rest.
Can I finance refurbished Fresenius 2008T machines?
Yes, and many centers do. Certified refurbished 2008T units cost a fraction of new, and we finance them on the same application-driven path, mixing new and refurbished stations on one schedule if you prefer.
Do you finance home and portable dialysis programs?
Yes. Home hemodialysis fleets such as Outset Tablo or NxStage, and peritoneal dialysis cyclers, can be financed as a program on a single facility, the same way we fund in-center stations.
We are a new center still credentialing with payers. Can we qualify?
Often yes. Several lenders in our network fund new dialysis centers against owner credit and the project, sometimes with a deferral so payments begin once treatments are billing. We will tell you honestly what the file supports.
Get Started Today
Apply online in 5 minutes or call (773) 900-7576. Soft credit look, no impact to apply. All credit profiles welcome, US medical providers only.